FlowCytoNews
Flow cytometry, gated weekly.
SPECIAL EDITION · NANOFLOW CYTOMETRY · OCT 7, 2026
Extracellular vesicles, viruses and lipid nanoparticles are now routine requests at flow cores. Most of those particles are smaller than the noise floor of the cytometer they get run on. This special edition replaces our usual Wednesday calendar with a field guide to nanoflow: what each instrument actually claims, what the last year of papers says about calibration and pitfalls, which standards apply, and a checklist to run before you report a single EV number. Tell us what we missed — hit reply.
■ Why small particles are hard
For particles well below the laser wavelength, scattered light falls off roughly with the sixth power of diameter. Halve the size and you lose about 98% of the signal. Two consequences shape everything below.
"40 nm" depends on what you measured. Vendors quote the smallest polystyrene or silica bead they can resolve. Polystyrene has a refractive index near 1.59; an EV is closer to 1.37–1.40, so a 40 nm EV scatters far less than a 40 nm polystyrene bead. A bead claim is a sensitivity benchmark, not the smallest EV you will see.
Concentration can fool you. When many dim particles sit in the laser at once they are counted as one brighter event ("swarm detection"). Plasma adds lipoproteins that outnumber EVs and overlap them in size. Both inflate or distort counts unless you dilute and control for them.
■ The instruments
What each vendor says its system can detect, in the vendor's own terms. Listed alphabetically by company. The numbers are not comparable across rows unless the bead material matches.
Company · system | Small-particle claim (as stated) | Since |
|---|---|---|
Agilent · NovoCyte Quanteon | "Particles as small as 100 nm were easily resolved from the background" (polystyrene, app note) | App note, Oct 2019 |
Apogee Flow Systems · Micro / MicroPLUS, "Iota" upgrade | MicroPLUS: biological particles "down to about 100nm". Iota upgrade: "10x Fluorescence Sensitivity Boost"; scatter "down to 40nm polystyrene test beads" | Iota upgrade, May 2026 |
Beckman Coulter Life Sciences · CytoFLEX nano | "Detection to at least 40 nm" (polystyrene, violet side-scatter trigger); 6 fluorescence and 5 side-scatter channels | Mar 2024 |
Bio-Rad · ZE5 Small Particle Detector kit | Secondary FSC detector off the 405 nm laser for "bacteria and exosomes"; no size figure given | Upgrade kit |
Cytek Biosciences · Enhanced Small Particle (ESP); Aurora Evo | ESP: "particles as small as 70 nm can be studied label-free". Built into the Aurora Evo; available on the Aurora CS sorter | ESP May 2024; Evo May 2025 |
NanoFCM · Flow NanoAnalyzer | EVs "down to 40 nm"; MS2 virus (27 nm) detected; silica calibration 43–113 nm; up to 12,000 particles/min | On market |
Sony Biotechnology · ID7000 | Resolves "160-nm beads" from noise | On market |
Thermo Fisher · Attune NxT / Attune Xenith | NxT: 0.2 µm on side scatter (0.1 µm under stated conditions). Xenith: a violet scatter channel "optimized for small particle detection" | Spec sheet, Mar 2026 |
Waters Biosciences (BD) · FACSDiscover A8 | V-SSC separates "160 nm polystyrene beads from noise" | May 2025 |
▪ Sources: Agilent · Apogee · Beckman · Bio-Rad · Cytek · NanoFCM · Sony · Thermo Fisher · BD/Waters
Why it matters: No vendor publishes a price, and none states the smallest EV it detects in EV terms. If you are writing an equipment request, ask each vendor to run the same silica or EV-mimic reference particles on a demo, and calibrate the results to diameter and MESF yourself (FCMPASS, below). That is the only like-for-like comparison.
■ What the last year of papers says
Calibration cuts inter-lab disagreement by more than half
Britta Bettin, Edwin van der Pol (Amsterdam UMC) and a large multi-site group, including NIST and NCI, measured the same EV samples on 25 flow cytometers. Calibrating scatter and fluorescence "reduces the median absolute deviation of EV concentrations measured on 25 different FCMs from 67 % to 25 %-31 %." With calibrated instruments they set reference ranges for erythrocyte-, leukocyte- and platelet-derived EVs in 224 healthy individuals. Co-authors include staff of BD Biosciences, Exometry, Cellarcus Biosciences and Nanostics.
▪ J Extracell Vesicles · Dec 2025 · 10.1002/jev2.70189
The "dilution paradox": up to two-thirds of clinical EV measurements were unreliable
Labs usually dilute each plasma sample to hit a target particle concentration. Joyce Rops and van der Pol (Amsterdam UMC) show why that backfires: "plasma samples are diluted based on their particle concentration, which can differ 100-fold between samples," so background and swarm effects differ sample to sample. "In the two clinical studies, 30% and 65% of the measurements were unreliable, depending on the label used." A companion re-analysis with Ceren Eyileten (Medical University of Warsaw) of two cardiovascular EV studies found "47% (1156/2457) of the evaluated measurements are unreliable" and recommends a fixed dilution factor.
▪ J Extracell Vesicles · Jun 2026 · 10.1002/jev2.70312 · Res Pract Thromb Haemost · May 2026 · 10.1016/j.rpth.2026.106636
Why it matters: If your EV assay normalizes input by particle count, your between-patient differences may partly be dilution artifacts. These two papers are the citation for switching to a fixed dilution.
Independent test drives of the CytoFLEX nano
Jonathan Burnie and Kizzmekia Corbett-Helaire (Harvard T.H. Chan School of Public Health) compared the CytoFLEX nano with a CytoFLEX S on beads, HIV and EVs. The nano gave "up to 50-fold higher signal-to-noise ratio" and resolved beads of 70 nm and below that the S could not see. The trade-offs are stated plainly: sample flow is 1 µL/min versus 10 µL/min, the collinear lasers add spillover, and PE sensitivity was no better. Separately, Brittany Rein and Steven Madore (ICBR, University of Florida) sized lipid nanoparticles against cryo-EM (68.9 ± 16.3 nm). CytoFLEX nano (69.5 nm) and NanoFCM (about 65 nm) agreed with it; NTA (83.0 nm) and DLS (85–92 nm; the paper reports two values) read high.
▪ Virol J · Apr 2026 · 10.1186/s12985-026-03169-3 · J Biomol Tech · Jun 2026 · 10.7171/001c.163225
Single-EV phenotyping, done carefully
Nathalie Nevo and Clotilde Théry (INSERM U932, Institut Curie) used a Flow NanoAnalyzer to compare EV subpopulations across cell types and drug treatments, detecting "particles smaller than 200 nm in diameter, without the need for vesicle pre-immobilisation or fluorescent labels." They set out a best-practice triad: titrate antibodies, remove unbound antibody, and use marker-negative EVs as controls.
▪ J Extracell Vesicles · Apr 2026 · 10.1002/jev2.70271
Reagents are the weak link: antibodies, dyes and probe size
Three papers this year point at labels rather than instruments. Tobias Tertel and Alexander Schramm (University Hospital Essen) profiled PD-L1 on EVs by imaging flow and found that "despite being derived from the same clone, antibodies from different manufacturers showed striking differences in labelling efficiency." Petra Vrdoljak and An Hendrix (Ghent University) compared six membrane and luminal dyes by nano-flow and concluded "no single dye is universally suitable for EV labeling." Yunyun Hu and Xiaomei Yan (Xiamen University) showed that bulky antibody conjugates block each other on small EVs, then recovered double-positive events with nanobodies; dual PD-L1/CD47 detection on plasma EVs "achieved an overall accuracy of 90.0% for breast cancer diagnosis." Yan co-founded NanoFCM, the maker of the nano-flow instrument, according to her disclosure in an earlier paper.
▪ J Extracell Biol · May 2026 · 10.1002/jex2.70144 · J Extracell Vesicles · May 2026 · 10.1002/jev2.70291 · Small Methods · Sep 2026 · 10.1002/smtd.71053 · Yan disclosure: 10.1002/jev2.12206
Also out
Dim calibration beads for EVs. Marcell Pálmai and Zoltán Varga (HUN-REN Research Centre for Natural Sciences, Budapest) made fluorescent silica particles "as low as 278 MESF with narrow distribution," dim enough to calibrate EV fluorescence. — Sci Rep · Sep 1 · 10.1038/s41598-026-60804-3
Three instruments, three answers. Premanshu Singh and Shaurya Prakash (Ohio State) ran the same EVs on NanoFCM, CytoFLEX nano and ZetaView; size distributions, concentrations and tetraspanin levels all differed with optical design. — J Extracell Biol · Jun 2026 · 10.1002/jex2.70154
A clinical claim to read critically. Yuanchu Zheng and Tao Feng (Beijing Tiantan Hospital) measured tau-positive neuron-derived EVs by nano-scale flow in 188 people across three centres; in the validation cohort the model reached an AUC of 0.971 for progressive supranuclear palsy versus controls and 0.990 versus Parkinson's disease. Neuron-derived EV isolation remains contested. — Brain · Mar 2026 · 10.1093/brain/awag091
■ Standards and tools
MIFlowCyt-EV (2020) is the reporting framework from the ISEV-ISAC-ISTH EV Flow Cytometry Working Group: controls, calibration and units to report. 10.1080/20013078.2020.1713526
MISEV2023 is ISEV's general EV guidance and points to MIFlowCyt-EV for flow. 10.1002/jev2.12404
FCMPASS (NCI, free) converts scatter to approximate diameter and refractive index and fluorescence to MESF. Version 3 adds per-cytometer databases, a MIFlowCyt-EV report and calibrated .fcs output. Its creator, Joshua Welsh, is now a senior staff scientist in Waters Biosciences' Advanced Technology Group. nano.ccr.cancer.gov/fcmpassdoc
Reference materials are still missing. NIST lists EV reference materials as a goal, with no RM numbers yet. Its Dec 2025 study of commercial EVs found particle concentrations disagreed by "up to two orders of magnitude across methods" (flow was not one of them). There is no ISO or CLSI standard specific to EV flow. NIST
EV mimics are coming to market. Slingshot Biosciences lists NanoCytes, "fluorescently-labeled nanoparticles that match the optical properties of real extracellular vesicles (EVs)," engineered "with the size and refractive index of extracellular vesicles" for EV flow cytometry. The product page says NanoCytes are "coming soon"; sizes, labels and pricing are not yet published. slingshotbio.com
■ On the calendar
Meeting | Dates · place | Deadline |
|---|---|---|
AAEV 2026 (American Society for Extracellular Vesicles) | Nov 12–15, 2026 · Jersey City, NJ | — |
GRC RNA Nanotechnology (includes EV delivery) | Jan 10–17, 2027 | Applications due Dec 13, 2026 |
May 5–9, 2027 · BEXCO, Busan | Abstracts close Jan 11, 2027 | |
Jun 5–9, 2027 · Helsinki | — |
■ Bench Notes
Five checks before you report an EV concentration
Calibrate both axes. Run reference beads of known size and refractive index for scatter and MESF beads for fluorescence, and convert to nm and MESF with FCMPASS or equivalent. Report the detection limit in those units, not in arbitrary channels. This is the step that halved inter-lab spread in Bettin et al.
Prove you are counting single particles. Run a serial dilution of a sample. Event rate should fall in proportion to dilution while median fluorescence and scatter stay flat. If median signal changes, you are in swarm.
Use a fixed dilution, not a target concentration. Per Rops et al., dilute every sample in a study by the same factor so background and coincidence are comparable across patients.
Run the controls MIFlowCyt-EV asks for. Buffer-only, buffer plus reagents (antibody aggregates are a common false positive), unstained sample, and a detergent-lysis control to show that positive events are membrane-bound vesicles.
Qualify every antibody and dye on EVs. Titrate on EVs, not cells; remove unbound reagent; include marker-negative EVs; and record clone, vendor and lot. Same-clone antibodies from different vendors behaved differently in Tertel et al.
Running nanoflow in your core or lab? Hit reply with what works and what doesn't — the best notes run in a future edition. If a colleague is about to buy a small-particle cytometer, forward this to them.